Key result
Transcatheter tricuspid valve implantation of the NaviGate valved stent was successfully performed in a swine model with excellent hemodynamic performance and no conduction or coronary complications.
Why the study?
Does transcatheter tricuspid valve implantation of the NaviGate valved stent demonstrate feasibility and safety in a long-term swine model?
Does transcatheter tricuspid valve implantation of the NaviGate valved stent demonstrate feasibility and safety in a long-term swine model?
The NaviGate valved stent demonstrates feasibility and excellent hemodynamic performance for transcatheter tricuspid valve implantation in a preclinical swine model.
No takes yet. Share an insight, caveat, or question.
Feasibility shown in swine; leaves open human translation for tricuspid regurgitation therapy.
Navia et al. (2018) studied Tricuspid regurgitation. Transcatheter tricuspid valve implantation of the NaviGate valved stent was evaluated on Feasibility, hemodynamic and valve performance, conduction disturbance, and coronary obstruction. Transcatheter tricuspid valve implantation of the NaviGate valved stent was successfully performed in a swine model with excellent hemodynamic performance and no conduction or coronary complications.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: